| |
| |
|
| Insider
Information: |
Kellogg Peter N |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
223,030 |
|
|
Indirect Shares
|
480 |
|
|
| Direct
Value |
$29,023,263 |
|
|
|
Indirect Value
|
$51,955 |
|
|
| Total
Shares |
223,510 |
|
|
| Total
Value |
$29,075,218 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
EVP, Finance and CFO |
2007-03-20 |
18,966 |
2004-02-06 |
0 |
Premium* |
|
|
Merck & Co Inc |
MRK |
Exe V-P & CFO |
2014-02-24 |
149,553 |
2010-11-13 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
Director |
2017-06-30 |
5,302 |
2015-09-10 |
0 |
Premium* |
|
|
Celgene Corp |
CELG |
|
2018-05-04 |
49,209 |
2018-05-04 |
480 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
43 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CELG |
Celgene Corp |
See Remarks |
• – – |
2016-02-12 |
4 |
D |
$102.45 |
$415,537 |
D/D |
(4,056) |
3,766 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2017-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,820 |
5,302 |
0 |
- |
|
| CELG |
Celgene Corp |
See Remarks |
• – – |
2016-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,822 |
7,822 |
0 |
- |
|
| CELG |
Celgene Corp |
See Remarks |
• – – |
2017-02-14 |
4 |
D |
$117.02 |
$891,341 |
D/D |
(7,617) |
10,833 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2015-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
12,500 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP - Finance, CFO |
• – – |
2004-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
15,000 |
|
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Finance and CFO |
• – – |
2006-09-19 |
4 |
AS |
$42.70 |
$942,533 |
D/D |
(22,033) |
17,087 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Finance and CFO |
• – – |
2007-02-06 |
4 |
D |
$48.94 |
$389,220 |
D/D |
(7,953) |
17,668 |
0 |
- |
|
| CELG |
Celgene Corp |
See Remarks |
• – – |
2017-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
14,684 |
18,450 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Finance and CFO |
• – – |
2007-02-13 |
4 |
AS |
$49.22 |
$502,102 |
D/D |
(10,202) |
18,966 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Finance and CFO |
• – – |
2007-03-20 |
4 |
AS |
$44.48 |
$322,561 |
D/D |
(7,252) |
18,966 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Exe V-P & CFO |
• – – |
2010-11-13 |
4 |
D |
$34.71 |
$643,523 |
D/D |
(18,540) |
21,460 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Finance and CFO |
• – – |
2007-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,534 |
25,621 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Finance and CFO |
• – – |
2007-03-14 |
4 |
D |
$44.11 |
$229,284 |
D/D |
(5,198) |
26,218 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Finance and CFO |
• – – |
2007-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
11,500 |
29,168 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Exe V-P & CFO |
• – – |
2011-02-22 |
4 |
A |
$32.34 |
$293,744 |
D/D |
9,083 |
30,752 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Finance and CFO |
• – – |
2007-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
12,450 |
31,416 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
Director |
– • – |
2017-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
22,321 |
34,821 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Exe V-P & CFO |
• – – |
2011-02-28 |
4 |
D |
$32.19 |
$136,904 |
D/D |
(4,253) |
38,199 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Finance and CFO |
• – – |
2006-09-14 |
4 |
D |
$43.39 |
$562,638 |
D/D |
(12,967) |
39,120 |
0 |
- |
|
| CELG |
Celgene Corp |
See Remarks |
• – – |
2017-08-01 |
4 |
D |
$135.18 |
$4,205,450 |
D/D |
(31,110) |
39,723 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Exe V-P & CFO |
• – – |
2010-11-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
40,000 |
40,000 |
0 |
- |
|
| CELG |
Celgene Corp |
See Remarks |
• – – |
2017-10-27 |
4 |
D |
$98.17 |
$106,809 |
D/D |
(1,088) |
40,735 |
0 |
- |
|
| CELG |
Celgene Corp |
See Remarks |
• – – |
2017-10-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,100 |
41,823 |
0 |
- |
|
| CELG |
Celgene Corp |
See Remarks |
• – – |
2017-12-19 |
4 |
D |
$107.06 |
$189,282 |
D/D |
(1,768) |
42,377 |
0 |
- |
|
43 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
